REGULATED PRESS RELEASE published on 03/29/2024 at 17:45, 2 years 2 months ago NFL BIOSCIENCES: 2023 FULL-YEAR BUSINESS AND EARNINGS UPDATE
BRIEF published on 03/11/2024 at 09:00, 2 years 3 months ago NFL BIOSCIENCES: INITIATION OF ANALYST COVERAGE BY PORTZAMPARC - BNP PARIBAS GROUP NFL Biosciences PORTZAMPARC BNP Paribas Biopharmaceutical Industry Analyst Coverage
BRIEF published on 03/11/2024 at 09:00, 2 years 3 months ago NFL BIOSCIENCES : INITIATION DE COUVERTURE ANALYSTE PAR PORTZAMPARC – GROUPE BNP PARIBAS Marché Financier NFL Biosciences PORTZAMPARC BNP Paribas Couverture Analyste
REGULATED PRESS RELEASE published on 03/11/2024 at 08:55, 2 years 3 months ago NFL BIOSCIENCES: INITIATION OF ANALYST COVERAGE BY PORTZAMPARC - BNP PARIBAS GROUP
REGULATED PRESS RELEASE published on 03/11/2024 at 08:55, 2 years 3 months ago NFL BIOSCIENCES : INITIATION DE COUVERTURE ANALYSTE PAR PORTZAMPARC – GROUPE BNP PARIBAS
ARTICLE published on 02/13/2024 at 18:45, 2 years 4 months ago NFL BIOSCIENCES ANNONCE SA PARTICIPATION AU CONGRÈS DE LA SRNT Présentation des résultats prometteurs de l'étude PRECESTO dans la lutte contre le tabagisme NFL Biosciences Innovation NFL-101 Tabagisme SRNT
REGULATED PRESS RELEASE published on 02/13/2024 at 17:45, 2 years 4 months ago NFL BIOSCIENCES WILL PRESENT THE RESULTS OF THE PRECESTO CLINICAL STUDY AT THE SRNT CONFERENCE, THE WORLD'S LEADING SCIENTIFIC SOCIETY IN THE FIELD OF NICOTINE AND TOBACCO RESEARCH NFL Biosciences to present promising results of the PRECESTO clinical study at the SRNT Conference, focusing on smoking cessation with botanical drug NFL-101. Phase 2b trial ongoing for CESTO 2 NFL Biosciences Smoking Cessation NFL-101 PRECESTO Study CESTO 2
REGULATED PRESS RELEASE published on 02/13/2024 at 17:45, 2 years 4 months ago NFL BIOSCIENCES PRÉSENTERA LES RÉSULTATS DE L’ÉTUDE PRECESTO LORS DU CONGRÈS DE LA SRNT, LA SOCIÉTÉ SCIENTIFIQUE DE RÉFÉRENCE AU NIVEAU MONDIAL DANS LA LUTTE CONTRE LE TABAGISME NFL Biosciences présentera les résultats de l'étude PRECESTO lors du congrès de la SRNT à Édimbourg le 20-23 mars 2024, montrant l'efficacité de NFL-101 dans la réduction de la satisfaction de fumer NFL Biosciences NFL-101 Étude PRECESTO Tabagisme SRNT
REGULATED PRESS RELEASE published on 01/30/2024 at 08:00, 2 years 4 months ago NFL BIOSCIENCES: SUCCESS OF THE STUDY WITH THE CEA NFL BIOSCIENCES announces the successful study with the CEA demonstrating a new mechanism of action for smoking cessation using NFL-101, a botanical drug. Results open new possibilities for addiction treatment NFL Biosciences Addiction Treatment CEA Study Smoking Cessation NFL-101
REGULATED PRESS RELEASE published on 01/30/2024 at 08:00, 2 years 4 months ago NFL BIOSCIENCES : SUCCÈS DE L’ÉTUDE AVEC LE CEA NFL BIOSCIENCES annonce la mise en ubrique, étude d'imagerie moléculaire menée par le CEA, du mécanisme d'action innovant du candidat médicament NFL-101 pour le sevrage tabagique NFL Biosciences Étude D'imagerie Moléculaire Sevrage Tabagique CEA Mécanisme D'action
Published on 06/25/2026 at 00:30, 5 hours 30 minutes ago Northern Dynasty Reports Annual General Meeting Results and Welcomes New Directors
Published on 06/24/2026 at 23:05, 6 hours 55 minutes ago Polaris Modifies Quorum Requirement for Upcoming AGM
Published on 06/24/2026 at 22:15, 7 hours 45 minutes ago Organto Foods Announces Annual General Meeting Results
Published on 06/24/2026 at 21:20, 8 hours 40 minutes ago Taranis to Explore New Properties East of Thor Mineral Resource
Published on 06/24/2026 at 20:10, 9 hours 50 minutes ago Fox River Obtains Final Order Approving Plan of Arrangement With Avenir Minerals Limited
Published on 06/25/2026 at 03:20, 2 hours 40 minutes ago ZTT at Intersolar Europe 2026: Full-Industry-Chain Strength Powering a Low-Carbon Future
Published on 06/24/2026 at 23:57, 6 hours 3 minutes ago OHB: Upsized private placement worth EUR 900 million successfully completed
Published on 06/24/2026 at 20:54, 9 hours 6 minutes ago EQS-Adhoc: Branicks Group AG sets out timetable for the publication of its 2025 annual and consolidated financial statements
Published on 06/24/2026 at 19:00, 11 hours ago ALTAREA - Succès de l’option pour le paiement du dividende en actions : taux de souscription de 78,5 %
Published on 06/24/2026 at 18:00, 12 hours ago KERLINK : Assemblée générale mixte des actionnaires du 23 juin 2026 Seconde convocation le 9 juillet 2026.
Published on 06/24/2026 at 17:45, 12 hours 15 minutes ago Air Liquide poursuit son développement au Kazakhstan avec un investissement clé pour le complexe industriel de Silleno